Actually, CTLN2 has been reported to be related to hepatocellular carcinoma (HCC) [6, 7], and the incidence of this malignancy was estimated to be approximately 8% in CTLN2 patients [8]. The gene discussed is SLC25A13; the disease is hepatocellular carcinoma.